Form 4 for MIRM Mirum Pharmaceuticals, Inc.
Accepted 2023-05-04 00:00:00 ET · period of report 2023-05-03 · accession 0001209191-23-027549 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-05-04 | 2023-05-03 | MIRM | GREY MICHAEL G | Dir | S - Sale+OE | $28.00 | -14.6K | 0 | -100% | -$409.0K |
| D | 2023-05-04 | 2023-05-03 | MIRM | GREY MICHAEL G | Dir | M - OptEx | $2.94 | +14.6K | 14.6K | New | +$42.9K |
| D | 2023-05-04 | 2023-05-03 | MIRM | GREY MICHAEL G | Dir | M - OptEx | $0.00 | -14.6K | 360.4K | -4% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-03 | S | D | 14,608 | $28.00 | 0 | D | — | — | |
| 2 | Common | Common Stock | 2023-05-03 | M | A | 14,608 | $2.94 | 14,608 | D | — | — | |
| 3 | Derivative | Stock Option (right to buy) | 2023-05-03 | M | D | 14,608 | $0.00 | 360,392 | D | $2.94 · — to 2029-03-11 | 14,608 Common Stock | (F2) 1/4th of the shares vest one year after November 5, 2018, and the balance of the shares vest in a series of 36 successive equal monthly installments at the end of each month thereafter. The shares subject to this option are early exercisable, subject to the Issuer's right of repurchase. |